FDA Drug recall D-0970-2017
ZRECT for Women Herbal Dietary Supplement Capsules, 500 mg, supplied in 30 count packages, Distributed by Organic Herbal Supply, Roseville,…
- FDA Drug
- Class I
- terminated
- Published 2017-07-19
On 2017-07-19 the FDA classified a Class I recall of ZRECT for Women Herbal Dietary Supplement Capsules, 500 mg, supplied in 30 count packages, Distributed by Organic Herbal Supply, Roseville,… by Organic Herbal Supply, citing marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0970-2017 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2017-04-18 |
| Published | 2017-07-19 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Organic Herbal Supply |
| Distribution | US |
Product
ZRECT for Women Herbal Dietary Supplement Capsules, 500 mg, supplied in 30 count packages, Distributed by Organic Herbal Supply, Roseville, CA --- UPC Code 680474229055
Reason
Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin
Identifiers
| upc | 680474229055 |
|---|---|
| code_info | All lots and package sizes |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0970-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.